TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ancel Medicin AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
43
|
70
|
51 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
30
|
61
|
42 |
EBITDA |
30
|
62
|
42 |
Total assets |
141
|
149
|
104 |
Current assets |
111
|
124
|
83 |
Current liabilities |
6
|
17
|
12 |
Equity capital |
135
|
121
|
88 |
- share capital |
5
|
4
|
5 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
95.7%
|
81.2%
|
84.6% |
Turnover per employee |
43
|
70
|
51 |
Profit as a percentage of turnover |
69.8%
|
87.1%
|
82.4% |
Return on assets (ROA) |
21.3%
|
40.9%
|
40.4% |
Current ratio |
1850.0%
|
729.4%
|
691.7% |
Return on equity (ROE) |
22.2%
|
50.4%
|
47.7% |
Change turnover |
-27
|
23
|
20 |
Change turnover % |
-39%
|
49%
|
64% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.